Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | SATKARTAR Sat Kartar Shopping Ltd. Pharma · SME | BAFNAPH Bafna Pharmaceuticals Limited Pharma · Small | AMANTA Amanta Healthcare Limited Pharma · Small | INNOVANA Innovana Thinklabs Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 69 | 25 | 44 | 68 |
| Verdict | UNDERVALUED | OVERVALUED | WATCHLIST | UNDERVALUED |
| Style | Growth at Value | OVERVALUED | WATCHLIST | Growth at Value |
| Piotroski | 6/9 | 2/9 | 6/9 | 8/9 |
| Valuation | 17/30 | 5/30 | 9/30 | 19/30 |
| Growth | 23/25 | 9/25 | 21/25 | 19/25 |
| Quality | 17/20 | 0/20 | 0/20 | 8/20 |
| Balance Sheet | 12/15 | 11/15 | 7/15 | 12/15 |
| Cash Flow | 0/10 | 3/10 | 4/10 | 4/10 |
| Price | ₹160.2 | ₹174.58 | ₹135.46 | ₹300.55 |
| P/E | 14.80 | — | 31.80 | 16.20 |
| P/B | 3.73 | 0.81 | 2.38 | 2.28 |
| ROE | 28.70% | -6.18% | 10.40% | 16.00% |
| ROCE | 37.30% | -3.00% | 11.60% | 16.40% |
| Debt / Equity | 0.03 | 0.06 | 1.11 | 0.21 |
| FCF Yield | — | — | — | — |
| Dividend Y | 0.44% | — | — | — |
| Altman Z | 10.48 | 7.86 | 2.40 | 6.04 |
| Promoter % | 63.62% | 75.00% | 63.72% | 72.65% |
| Mkt Cap (₹Cr) | 252.00 | 407.00 | 523.00 | 617.00 |
| Graham # | ₹102.38 | — | ₹69.9 | ₹234.15 |
| Fair PE | 42.0 | 42.0 | 42.0 | 42.0 |
| MoS % | +64.9% | — | +15.8% | +61.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startSATKARTAR99
BAFNAPH212
AMANTA97
INNOVANA67